PRIMARY BILIARY CHOLANGITIS (PBC)
Clinical trials for PRIMARY BILIARY CHOLANGITIS (PBC) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY BILIARY CHOLANGITIS (PBC) trials appear
Sign up with your email to follow new studies for PRIMARY BILIARY CHOLANGITIS (PBC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a common cholesterol drug help treat a rare liver disease?
Disease control CompletedThis early-phase study tested whether adding fenofibrate (a cholesterol-lowering drug) to standard treatment with ursodeoxycholic acid improves liver function in 30 adults newly diagnosed with primary biliary cholangitis (PBC), a chronic liver disease. The main goal was to see if…
Matched conditions: PRIMARY BILIARY CHOLANGITIS (PBC)
Phase: EARLY_PHASE1 • Sponsor: Han Ying • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Online wellness program shows promise for easing PBC symptoms
Symptom relief CompletedThis study tested a 10-week online wellness program for women with primary biliary cholangitis (PBC), a chronic liver disease that causes fatigue, itching, brain fog, and emotional distress. The program included guided breathing, meditation, and gentle movement, plus optional nut…
Matched conditions: PRIMARY BILIARY CHOLANGITIS (PBC)
Phase: NA • Sponsor: University of Alberta • Aim: Symptom relief
Last updated May 22, 2026 13:55 UTC
-
New drug PVT201 tested in people for first time
Knowledge-focused CompletedThis early-stage study tested a single dose of PVT201 in 24 healthy volunteers and patients with primary biliary cholangitis (PBC) or primary sclerosing cholangitis (PSC). The main goal was to check safety and see how the drug moves through the body. Healthy volunteers received e…
Matched conditions: PRIMARY BILIARY CHOLANGITIS (PBC)
Phase: PHASE1 • Sponsor: Parvus Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 19, 2026 11:48 UTC